A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Part of paid clinical trials in Dothan, Alabama.
- Sponsor
- Genentech, Inc.
- Study ID
- NCT05037929
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- Astegolimab — DRUGParticipants will receive SC astegolimab Q2W or Q4W.
- Placebo — DRUGParticipants will receive SC placebo Q2W.
Study Details
This study will evaluate the efficacy, safety, and pharmacokinetics of astegolimab in combination with standard of care chronic obstructive pulmonary disease (COPD) maintenance therapy in patients with COPD who are former or current smokers and have a history of frequent exacerbations.
Key Dates
- First listed
- Sep 8, 2021
- Start date
- Oct 5, 2021
- Status verified
- Feb 2026
- Primary completion
- Feb 24, 2025
- Completion
- Jul 7, 2025
Study Design
- Enrollment
- 1,334 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Astegolimab Q2WParticipants will receive subcutaneous (SC) astegolimab every 2 weeks (Q2W).
- Experimental: Astegolimab Q4WParticipants will receive alternating SC astegolimab and placebo Q2W, thus receiving astegolimab every 4 weeks (Q4W).
- Placebo Comparator: PlaceboParticipants will receive SC placebo Q2W.
Primary Outcome Measure
Annualized Rate of Moderate and Severe COPD Exacerbations Over the 52-Week Treatment Period [ Time Frame: Baseline up to Week 52 ]
Locations (34)
Find similar trials in Dothan, AL
By condition
By specialty
By research site
Related Studies
- Emphysema Research Registry and Biosample RepositoryRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) StudyRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)PHASE2 · Recruiting · University of California, San Diego · La Jolla, California
- PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.Recruiting · Observational and Pragmatic Research Institute · Denver, Colorado